BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 19223425)

  • 1. Use of a voxel phantom as a source and a second voxel phantom as a target to calculate effective doses in individuals exposed to patients treated with 131I.
    de Carvalho AB; Hunt J; Silva AX; Garcia F
    J Nucl Med Technol; 2009 Mar; 37(1):53-6. PubMed ID: 19223425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimating radiation doses from multidetector CT using Monte Carlo simulations: effects of different size voxelized patient models on magnitudes of organ and effective dose.
    DeMarco JJ; Cagnon CH; Cody DD; Stevens DM; McCollough CH; Zankl M; Angel E; McNitt-Gray MF
    Phys Med Biol; 2007 May; 52(9):2583-97. PubMed ID: 17440254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3D calculation of absorbed dose for 131I-targeted radiotherapy: a Monte Carlo study.
    Saeedzadeh E; Sarkar S; Abbaspour Tehrani-Fard A; Ay MR; Khosravi HR; Loudos G
    Radiat Prot Dosimetry; 2012 Jul; 150(3):298-305. PubMed ID: 22069233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hospital discharge of patients with thyroid carcinoma treated with 131I.
    Venencia CD; Germanier AG; Bustos SR; Giovannini AA; Wyse EP
    J Nucl Med; 2002 Jan; 43(1):61-5. PubMed ID: 11801704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Could the treatment of differentiated thyroid carcinoma with 3.7 and 5.55 GBq of (131I)NaI, on an outpatient basis, be safe?
    de Carvalho JW; Sapienza M; Ono C; Watanabe T; Guimarães MI; Gutterres R; Marechal MH; Buchpiguel C
    Nucl Med Commun; 2009 Jul; 30(7):533-41. PubMed ID: 19436231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific absorbed fraction for Korean adult voxel phantom from internal photon source.
    Lee C; Park S; Lee JK
    Radiat Prot Dosimetry; 2007; 123(3):360-8. PubMed ID: 17110390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An investigation of voxel geometries for MCNP-based radiation dose calculations.
    Zhang J; Bednarz B; Xu XG
    Health Phys; 2006 Nov; 91(5 Suppl):S59-65. PubMed ID: 17023800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Organ S values and effective doses for family members exposed to adult patients following I-131 treatment: a Monte Carlo simulation study.
    Han EY; Lee C; Mcguire L; Brown TL; Bolch WE
    Med Phys; 2013 Aug; 40(8):083901. PubMed ID: 23927361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiation exposure for 'caregivers' during high-dose outpatient radioiodine therapy.
    Marriott CJ; Webber CE; Gulenchyn KY
    Radiat Prot Dosimetry; 2007; 123(1):62-7. PubMed ID: 16825250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose conversion coefficients calculated using tomographic phantom, KTMAN-2, for X-ray examination of cardiac catheterisation.
    Park SH; Lee JK; Lee C
    Radiat Prot Dosimetry; 2008; 128(3):351-8. PubMed ID: 17766255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiation dose to the upper spine from therapeutic administrations of iodine-131-sodium iodide.
    Stabin MG
    J Nucl Med; 1993 Apr; 34(4):695-6. PubMed ID: 8455090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimation of external radiation dose to caregivers of patients treated with radioiodine after thyroidectomy.
    Jeong KH; Jung JW; Kim CB; Ahn BC; Lee HK; Yoo SJ; Day O; Lee JK
    Health Phys; 2014 Apr; 106(4):466-74. PubMed ID: 24562067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CT dosimetry: getting the best from the adult Cristy phantom.
    Castellano IA; Dance DR; Evans PM
    Radiat Prot Dosimetry; 2005; 114(1-3):321-5. PubMed ID: 15933130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Environmental radiation exposure of a thyroid cancer patient resulting from adjuvant iodine radiotherapy].
    Chaś J; Kowalczyk A; Siekierzyński M; Dziuk E; Janiak MK
    Wiad Lek; 2001; 54 Suppl 1():312-20. PubMed ID: 12182042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Applicability and limitations of the Adam mathematical phantom with respect to radiological protection.
    Smiljanic I; Schultz FW
    Radiat Prot Dosimetry; 2004; 111(1):89-92. PubMed ID: 15367775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of point, line and volume dose calculations for exposure to nuclear medicine therapy patients.
    de Carvalho AB; Stabin MG; Siegel JA; Hunt J
    Health Phys; 2011 Feb; 100(2):185-90. PubMed ID: 21399434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiation dose and risk from fluoroscopically guided percutaneous transhepatic biliary procedures.
    Stratakis J; Damilakis J; Hatzidakis A; Perisinakis K; Gourtsoyiannis N
    J Vasc Interv Radiol; 2006 Jan; 17(1):77-84. PubMed ID: 16415136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiation dose to family members of hyperthyroidism and thyroid cancer patients treated with 131I.
    Pant GS; Sharma SK; Bal CS; Kumar R; Rath GK
    Radiat Prot Dosimetry; 2006; 118(1):22-7. PubMed ID: 16105892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of patient organ doses and effective doses using the VIP-Man adult male phantom for selected cone-beam CT imaging procedures during image guided radiation therapy.
    Gu J; Bednarz B; Xu XG; Jiang SB
    Radiat Prot Dosimetry; 2008; 131(4):431-43. PubMed ID: 18667400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimated dose rates to members of the public from external exposure to patients with 131I thyroid treatment.
    Dewji S; Bellamy M; Hertel N; Leggett R; Sherbini S; Saba M; Eckerman K
    Med Phys; 2015 Apr; 42(4):1851-7. PubMed ID: 25832075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.